SELECT LANGUAGE BELOW

Shake Shack introduces Good Fit Menu across the country in response to weight-loss trend

Shake Shack introduces Good Fit Menu across the country in response to weight-loss trend

Shake Shack Launches New High-Protein, Low-Carb Menu As dietary trends shift in the U.S., especially with the rise of weight loss medications, fast food chains are adapting their offerings. One notable example is Shake Shack, which recently introduced the Good Fit Menu, aimed at making it easier for health-conscious customers to order high-protein, low-carb meals. […]

Managing holiday meals while using GLP-1 weight-loss medications

Managing holiday meals while using GLP-1 weight-loss medications

Impact of GLP-1 Weight Loss Medications on Social Interactions GLP-1 medications can aid in weight loss and support blood sugar control, but they also have the potential to alter social interactions significantly. As the holiday season draws near, those taking obesity medications may struggle with family meals or larger gatherings. This is largely due to […]

Study suggests Eli Lilly’s weight-loss medication may reduce signals for binge eating.

Study suggests Eli Lilly's weight-loss medication may reduce signals for binge eating.

Researchers studying brain activity in patients with significant overeating issues found that Eli Lilly’s weight loss medicine, GLP-1, seems to temporarily reduce hunger signals in the brain’s “reward center.” This marks the first time direct brain activity measurements have been taken from individuals receiving tirzepatide—marketed as Mounjaro for diabetes and Zepbound for weight loss—which showcased […]

Trump plans to reveal reduced prices for weight-loss medications and broader Medicare eligibility.

Trump plans to reveal reduced prices for weight-loss medications and broader Medicare eligibility.

Trump’s Announcement on Drug Price Reductions Later today, President Trump is set to reveal that two prominent pharmaceutical companies will be cutting the prices of GLP-1 medications, which are often used for diabetes treatment and weight management. Additionally, the government plans to broaden eligibility for these drugs under Medicare. Novo Nordisk, based in Denmark, produces […]

Americans are relying on unregulated sellers for GLP-1 weight-loss medications.

Americans are relying on unregulated sellers for GLP-1 weight-loss medications.

Concerns Rise Over Unregulated GLP-1 Drug Sales As interest in GLP-1 medications surges, particularly for weight loss and diabetes management, many Americans are opting for unregulated sellers instead of traditional pharmacies. This shift often stems from high costs, insurance issues, and consistent shortages. The FDA has issued warnings regarding the “gray market” for GLP-1 drugs, […]

Weight-loss physician explains how GLP-1 medications also address chronic illness

Weight-loss physician explains how GLP-1 medications also address chronic illness

Recent research indicates that weight loss and diabetes medications, known as glucagon-like peptide-1 receptor agonists (GLP-1), could be beneficial for a range of other health issues. These issues include cardiovascular disease, arthritis, skin conditions, and potentially even cancer prevention. The use of these drugs is linked to a reduced risk of chronic diseases, with a […]